U.S Govenment Announces $450M Deal With Regeneron Pharmaceuticals

U.S Govenment Announces $450M Deal With Regeneron Pharmaceuticals

The combined forces of the Biomedical Advanced Research and Development Authority (BARDA), the U.S. Department of Health and Human Services, and the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense have just approved a $450M deal with Regeneron Pharmaceuticals, Inc. This $450 million contract is for Regeneron to manufacture and supply REGN-COV2. REGN-COV2 is Regeneron's investigational double-antibody cocktail for COVID-19 treatment and prevention. Regeneron is currently in Phase 2/3 of clinical trials for the...

patients demand pharma pricing transparency

Patients Demand Pharma Pricing Transparency

Patients want transparency.  In recent years, patients are facing higher deductibles and higher premiums according to the Kaiser Family Foundation, KFF. Patients are also seeing complex and unclear pricing when it comes to routine checkups and medical tests.  In some cases, these complex pricing databases help knowledgeable patients compare prices refeeding medical procedures. In most cases, most about pricing in the big pharma world are still a mystery to them. More patients demand pharma pricing transparency than ever. Most of...